Autoantibodies to ZNF346 were detected in the sera of 15 out of 96 CRC patients (15.6%) and in 2 out of 35 non-cancer control samples (5.7%) (Fig 1A). The gene discussed is ZNF346; the disease is colorectal carcinoma.